# Bruce Thompson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bruce-thompson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 120,376 |
| Field | Respiratory Support and Mechanisms |
| h-index | 136 |
| i10-index | 801 |
| Last Known Institution | The University of Melbourne |
| OpenAlex ID | https://openalex.org/A5006201777 |
| ORCID iD | https://orcid.org/0000-0002-5885-0652 |
| Works | 1,740 |

## Researcher papers

Showing 12 of 17.

- [Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016](https://scholariq.org/papers/surviving-sepsis-campaign-international-guidelines-for-management-of-sepsis-and/)
- [Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016](https://scholariq.org/papers/surviving-sepsis-campaign-international-guidelines-for-management-of-sepsis-and-2/)
- [Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes](https://scholariq.org/papers/cardiac-specific-troponin-i-levels-to-predict-the-risk-of-mortality-in-patients/)
- [The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material](https://scholariq.org/papers/the-berlin-definition-of-ards-an-expanded-rationale-justification-and/)
- [Drotrecogin Alfa (Activated) in Adults with Septic Shock](https://scholariq.org/papers/drotrecogin-alfa-activated-in-adults-with-septic-shock/)
- [Angiotensin II for the Treatment of Vasodilatory Shock](https://scholariq.org/papers/angiotensin-ii-for-the-treatment-of-vasodilatory-shock/)
- [Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy](https://scholariq.org/papers/acute-respiratory-distress-syndrome-subphenotypes-respond-differently-to/)
- [Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)](https://scholariq.org/papers/hydroxycarbamide-in-very-young-children-with-sickle-cell-anaemia-a-multicentre/)
- [Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial](https://scholariq.org/papers/treatment-with-allogeneic-mesenchymal-stromal-cells-for-moderate-to-severe-acute/)
- [Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life](https://scholariq.org/papers/childhood-predictors-of-lung-function-trajectories-and-future-copd-risk-a/)
- [Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study](https://scholariq.org/papers/assessment-of-functional-capacity-before-major-non-cardiac-surgery-an/)
- [Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19](https://scholariq.org/papers/effect-of-hydroxychloroquine-on-clinical-status-at-14-days-in-hospitalized/)

## Researcher topics

- [Respiratory Support and Mechanisms](https://scholariq.org/topics/respiratory-support-and-mechanisms/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Intensive Care Unit Cognitive Disorders](https://scholariq.org/topics/intensive-care-unit-cognitive-disorders/)

## Researcher university

- [The University of Melbourne](https://scholariq.org/institutions/the-university-of-melbourne/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.